RCP
CL icon

RIT Capital Partners’s Colgate-Palmolive CL Stock Holding History

RIT Capital Partners’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,036,300
Closed -$69M – 9
2015
Q4 		$69M Sell
1,036,300
-46,700
-4% -$3.11M 18.55% 1
2015
Q3 		$68.7M Buy
1,083,000
+266,000
+33% +$17.4M 16.04% 1
2015
Q2 		$53.4M Buy
+817,000
New +$55.4M 12.45% 4
2013
Q3 		– Sell
-122,000
Closed -$6.97M – 18
2013
Q2 		$6.97M Buy
+122,000
New +$7.24M 2.63% 11

Other funds holding CL

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RIT Capital Partners's CL Position: Q1 2016 in Review

RIT Capital Partners sold out of Colgate-Palmolive (CL) in Q1 2016, closing a stake of 1,036,300 shares — an estimated $69M sold.

RIT Capital Partners first reported a position in CL in Q2 2013 and held it in 4 quarters. The position peaked at $69M in Q4 2015. 1,262 funds tracked by Wall St. Rank hold CL as of Q1 2016.

  • RIT Capital Partners reported no remaining Colgate-Palmolive position as of Q1 2016 after selling out during the quarter.
  • RIT Capital Partners sold 1,036,300 Colgate-Palmolive shares in Q1 2016, an estimated $69M.
  • RIT Capital Partners first reported a position in Colgate-Palmolive in Q2 2013 and held it in 4 quarters.
  • RIT Capital Partners's Colgate-Palmolive position peaked at $69M in Q4 2015.
  • 1,262 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2016.

Based on RIT Capital Partners's 13F filing for Q1 2016, filed 9 May 2016.